Research and Markets has announced the addition of the "Europe Osteoarthritis Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The report provides insights into Osteoarthritis epidemiology, Osteoarthritis diagnosed patients, and Osteoarthritis treatment rate for EU5 pharmaceutical markets.

The study measures key indicators such as prevalence of Osteoarthritis derived from epidemiological analysis, percentage of patients diagnosed with Osteoarthritis, and percentage of patients treated with a therapy.

The study helps executives estimate Osteoarthritis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Osteoarthritis prevalence, Osteoarthritis diagnosis rate, and Osteoarthritis treatment rate for the period 2016 - 2025.

Key Features of the Report:

  • Osteoarthritis Patient Flow
  • Osteoarthritis Prevalence
  • Osteoarthritis Diagnosed Patients
  • Osteoarthritis Treated Patients

Key Topics Covered:

1. Osteoarthritis: Disease Definition

2. Osteoarthritis Patient Flow in Europe

3. Osteoarthritis Patient Flow in Germany

4. Osteoarthritis Patient Flow in France

5. Osteoarthritis Patient Flow in Spain

6. Osteoarthritis Patient Flow in Italy

7. Osteoarthritis Patient Flow in UK

For more information about this report visit http://www.researchandmarkets.com/research/bgdfq6/europe